Tempus AI Director Makes a Significant Stock Sale!

New insider activity at Tempus AI, Inc. Class A ( (TEM) ) has taken place on May 14, 2025.

Director Theodore Leonsis recently sold 770 shares of Tempus AI, Inc. Class A stock, generating a total of $51,020 from the transaction.

Recent Updates on TEM stock

Tempus AI, Inc. Class A experienced significant developments in the last 24 hours, with a notable increase in its price target driven by strong Q1 performance and strategic growth initiatives. The company’s recent earnings call highlighted a 75.4% year-over-year revenue increase, reaching $255.7 million, and a 99.8% rise in gross profit, underscoring its strong market position. Strategic partnerships, including a $200 million agreement with AstraZeneca and Pathos, are expected to enhance its market presence and drive future growth. Despite these positive developments, challenges such as negative adjusted EBITDA and reimbursement issues persist. However, the company’s optimistic forward-looking guidance, projecting full-year 2025 revenue of $1.25 billion, reflects confidence in its growth trajectory. Analysts have raised the price target due to better-than-expected contributions from the genomics segment and strategic acquisitions, indicating a promising outlook for Tempus AI.

Spark’s Take on TEM Stock

According to Spark, TipRanks’ AI Analyst, TEM is a Neutral.

Tempus AI’s strong revenue growth and strategic partnerships are promising, but financial instability, negative profitability, and high leverage are key risks. Mixed technical indicators and a weak valuation also contribute to a moderate overall score.

To see Spark’s full report on TEM stock, click here.

More about Tempus AI, Inc. Class A

YTD Price Performance: 83.04%

Average Trading Volume: 12,571,009

Technical Sentiment Signal: Strong Buy

Current Market Cap: $10.85B